Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 1
Developing Technologies for Early Detection of Breast Cancer: Summary of Public Workshop #2 Developing Technologies for Early Detection of Breast Cancer Summary of Public Workshop #2 Written by Laura Newman, M.A. Medical Writer For the Committee on the Early Detection of Breast Cancer National Cancer Policy Board INSTITUTE OF MEDICINE and COMMISSION ON LIFE SCIENCES NATIONAL RESEARCH COUNCIL Washington, D.C.
OCR for page 2
Developing Technologies for Early Detection of Breast Cancer: Summary of Public Workshop #2 INSTITUTE OF MEDICINE 2101 Constitution Avenue, N.W. Washington, DC 20418 NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance. Support for this project was provided by The Breast Cancer Research Foundation, the Carl J. Herzog Foundation, Mr. John K. Castle, the Jewish Healthcare Foundation (Pittsburgh), the Josiah Macy, Jr., Foundation, the Kansas Health Foundation, and the New York Community Trust. The views presented in this Workshop Summary are those of the workshop speakers, and are not necessarily those of the Institute of Medicine Committee on the Early Detection of Breast Cancer or of the sponsors. Additional copies of this Workshop Summary are available in limited quantities from the National Cancer Policy Board, 2101 Constitution Avenue, N.W., Washington, DC 20418; call (202) 334-1382. The full text of this summary is available on line at www.nap.edu. For more information about the Institute of Medicine, visit the IOM home page at www.iom.edu. Copyright 2000 by the National Academy of Sciences. All rights reserved. Printed in the United States of America.
OCR for page 3
Developing Technologies for Early Detection of Breast Cancer: Summary of Public Workshop #2 THE NATIONAL ACADEMIES National Academy of Sciences National Academy of Engineering Institute of Medicine National Research Council The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Academy has a mandate that requires it to advise the federal government on scientific and technical matters. Dr. Bruce M. Alberts is president of the National Academy of Sciences. The National Academy of Engineering was established in 1964, under the charter of the National Academy of Sciences, as a parallel organization of outstanding engineers. It is autonomous in its administration and in the selection of its members, sharing with the National Academy of Sciences the responsibility for advising the federal government. The National Academy of Engineering also sponsors engineering programs aimed at meeting national needs, encourages education and research, and recognizes the superior achievements of engineers. Dr. William A. Wulf is president of the National Academy of Engineering. The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of eminent members of appropriate professions in the examination of policy matters pertaining to the health of the public. The Institute acts under the responsibility given to the National Academy of Sciences by its congressional charter to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care, research, and education. Dr. Kenneth I. Shine is president of the Institute of Medicine. The National Research Council was organized by the National Academy of Sciences in 1916 to associate the broad community of science and technology with the Academy's purposes of furthering knowledge and advising the federal government. Functioning in accordance with general policies determined by the Academy, the Council has become the principal operating agency of both the National Academy of Sciences and the National Academy of Engineering in providing services to the government, the public, and the scientific and engineering communities. The Council is administered jointly by both Academies and the Institute of Medicine. Dr. Bruce M. Alberts and Dr. William A. Wulf are chairman and vice chairman, respectively, of the National Research Council.
OCR for page 4
Developing Technologies for Early Detection of Breast Cancer: Summary of Public Workshop #2 IOM COMMITTEE ON THE EARLY DETECTION OF BREAST CANCER JOYCE C. LASHOF, M.D., FACP, CHAIR Professor Emerita, School of Public Health, University of California at Berkeley CRAIG HENDERSON, M.D., VICE CHAIR Adjunct Professor of Medicine University of California at San Francisco D. CRAIG ALLRED, M.D. Professor of Pathology Baylor College of Medicine DEREK VAN AMERONGEN, M.D., FACOG Chief Medical Officer, Humana/Choice Care Cincinnati, OH WADE M. AUBRY, M.D. Vice President, The Lewin Group Associate Clinical Professor of Medicine University of California at San Francisco JANET K. BAUM, M.D., FACR Associate Professor, Harvard Medical School Director, Breast Imaging Beth Israel Deaconess Hospital, Boston SUZANNE W. FLETCHER, M.D. Professor, Harvard School of Medicine & School of Public Health Brigham and Women's Hospital, Boston MARTHE R. GOLD, M.D., M.P.H. Chair, Department of Community Health and Social Medicine City University of New York Medical School LEON GORDIS, M.D., D.P.H. Professor of Epidemiology Johns Hopkins School of Public Health & Hygiene DANIEL F. HAYES, M.D. Clinical Director, Breast Cancer Program Lombardi Cancer Center Georgetown University Medical Center CAROLINA HINESTROSA, M.A. Cofounder and Executive Director, Nueva Vida Silver Spring, MD JEAN J. LATIMER, Ph.D. Investigator, Magee-Womens Research Institute Assistant Professor, University of Pittsburgh RICHARD R. NELSON, Ph.D. George Blumenthal Professor of International and Public Affairs School of Law, Columbia University KENNETH OFFIT, M.D., M.P.H. Chief, Clinical Genetics Service Department of Human Genetics Memorial Sloan-Kettering Cancer Center New York City FAINA SHTERN, M.D. Director, Office of Research Affairs Department of Radiology Beth Israel-Deaconess Medical Center Harvard Medical School MICHAEL W. VANNIER, M.D. Professor and Head, Department of Radiology University of Iowa College of Medicine Liaison for the National Cancer Policy Board ROBERT DAY, M.D., M.P.H., Ph.D. Emeritus President and Director Fred Hutchinson Cancer Research Center Staff SHARYL J. NASS, Ph.D., Study Director ROGER HERDMAN, M.D., Director, National Cancer Policy Board CARMIE CHAN, Research Assistant BIANCA L. TAYLOR, Project Assistant NICCI DOWD, Administrative Assistant KEVIN COLLINS, Intern
Representative terms from entire chapter: